The Ninebot/AIMA share price ratio has failed to track the trend in the forward EPS ratios since mid-March 2023. The upcoming index outflow event could act as a catalyst for this ratio to dip.
Boomeranged on Wed, 25 Oct 2023 12:48
Final Expectations for the Dec 23 STAR 50 Rebalance: Sichuan Biokin Pharmaceutical (688506 CH) is an expected ADD and Ninebot (689009 CH) is an expected DEL. The SHORT Ninebot vs LONG AIMA Tech trade has started to move in the right direction and might be worth revisiting.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.